feed,title,long_url,short_url
SeekingAlpha,Gilead Looks Fully Valued For 2023,https://seekingalpha.com/article/4571558,
SeekingAlpha,Week In Review: Mabwell Out-Licenses Rare Disease Drug For $412.5 Million,https://seekingalpha.com/article/4571564,
